Alphatec Holdings, Inc. (NASDAQ: ATEC)

Alphatec Holdings, Inc., also known as ATEC, is a medical technology company that operates in the healthcare industry. The company is renowned for its design, development, and advancement of technology for improved surgical treatment of spine disorders. With its headquarters in Carlsbad, California, ATEC is dedicated to revolutionizing the approach to spine surgery through clinical distinction.

ATEC's primary business activities revolve around the creation of sophisticated surgical solutions for spine disorders. These solutions integrate seamlessly with the expanding Alpha InformatiX product platform, which aims to objectively inform surgery and achieve the goals of spine surgery more predictably and reproducibly. The company's product portfolio is comprehensive, addressing various spine pathologies and designed to meet the specific requirements of each surgical approach.

The company generates revenue through the sale of its primary products, which include implants, fixation systems, access systems, and biologics. Each of these categories is designed to address specific aspects of spine surgery. For instance, implants and fixation systems provide fixation and stabilization for the spine, while access systems offer surgeons access to the spine. Biologics, on the other hand, facilitate spinal fusion, making them an essential part of ATEC's product portfolio.

ATEC's position within the industry is strong, with a growing market share and a reputation for innovation and clinical distinction. The company competes with other medical technology companies specializing in spine surgery, such as Medtronic and Stryker. Despite the competition, ATEC's commitment to innovation and clinical excellence sets it apart.

ATEC's customers include spine surgeons, hospitals, and healthcare systems. The company's products are used to treat a range of spine pathologies, including degenerative disc disease, spinal stenosis, and scoliosis.

ATEC's product portfolio includes the Lateral Franchise, a comprehensive portfolio of products and technologies designed to treat the spine laterally. The franchise includes the Sigma-PTP Access System, which provides a single-position surgery solution for the treatment of degenerative disc disease and other spine pathologies.

The Posterior Fixation System is another key product category, designed to provide fixation and stabilization for the spine. The Invictus Posterior Fixation System, a comprehensive spinal fixation solution, is a notable product in this category.

ATEC's Biologics portfolio includes a range of products designed to facilitate spinal fusion, including allograft and synthetic biologics. Access Systems are designed to provide surgeons with access to the spine, with the Sigma-ALIF Access System being a procedure-specific access system that allows for custom anterior abdominal exposure.